Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
| Company dealt in | Willis Towers Watson plc |
| Class of relevant security to which the dealings being disclosed relate (Note 2) | US$0.000304635 ordinary shares |
| Date of dealing | 16 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| | Long | Short | ||||
| | Number | | (%) | Number | | (%) |
| (1) Relevant securities | 1,703,926 1.32 | 1,563,113 1.21 | ||||
| (2) Derivatives (other than options) | 1,474,976 1.14 | 1,554,863 1.21 | ||||
| (3) Options and agreements to purchase/sell | | | ||||
| Total | 3,178,902 2.46 | 3,117,976 2.42 | ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
|
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
| Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases Purchases
Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales Sales | 3 100 300 100 55,233 19 23 157 3 70 26 54 168 98 100 92 300 100 343 84 1,300 2,564 100 126 19 7 108 529 3
2 3 11 200 300 200 7 3 2 43 9 4 2 2 2 2 2 2 3,908 19 100 6 2,016 100 100 192 200 2,564 467 70 100 100 348 100 278 558 200 400 100 4 100 1 9 2 114 3 7 120 1,470 | 237.9800 USD 240.6563 USD 240.9205 USD 240.9053 USD 240.4000 USD 241.1700 USD 240.5800 USD 240.3725 USD 241.0750 USD 241.2537 USD 240.4200 USD 241.3624 USD 240.8420 USD 241.2095 USD 239.9300 USD 239.9400 USD 240.3820 USD 241.2000 USD 240.3728 USD 240.4850 USD 240.3900 USD 240.4855 USD 240.9400 USD 241.4600 USD 240.9700 USD 240.9014 USD 240.0570 USD 240.6011 USD 238.8950 USD
238.4700 USD 237.9800 USD 237.9300 USD 240.6563 USD 240.9205 USD 240.9053 USD 238.4943 USD 240.1367 USD 240.0400 USD 239.6265 USD 240.1711 USD 239.9450 USD 240.1100 USD 240.2900 USD 239.7100 USD 240.3700 USD 239.7200 USD 239.8200 USD 240.4000 USD 241.1700 USD 241.1000 USD 241.2200 USD 240.4205 USD 240.5200 USD 240.3000 USD 239.9348 USD 241.2000 USD 240.4855 USD 237.4823 USD 239.0200 USD 237.4900 USD 237.3300 USD 237.5156 USD 238.7100 USD 237.2163 USD 240.4666 USD 238.4800 USD 237.6150 USD 237.4100 USD 239.1450 USD 238.2100 USD 239.8300 USD 239.7478 USD 239.9200 USD 242.2000 USD 240.0800 USD 240.4800 USD 241.0567 USD 237.7589 USD |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
| Equity Swap | Increase Short | 2,564 | 240.4855 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
| | | | | | | |
(ii) Exercising
| Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
| | | |
(d) Other dealings (including transactions in respect of new securities) (Note 4)
| Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
| | | |
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
| Date of disclosure | 19 April 2021 |
| Contact name | Alwyn Basch |
| Telephone number | 0207 742 7407 |
| If a connected EFM, name of offeree/offeror with which connected | N/A |
| If a connected EFM, state nature of connection (Note 10) | N/A |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
